Overview
Compare with EDUCATIONAL DEVELOPMENT CORP, HYDROFARM HOLDINGS GROUP, INC. or QUEST PATENT RESEARCH CORP, or pick any stock.
- TickerNHTC on Nasdaq2
- IndustryWholesale-Miscellaneous Nondurable Goods2
- HeadquartersRolling Hills Estates, United States2
- Incorporated inDE3
- Business address609 Deep Valley Drive, Suite 395, Rolling Hills Estates, Ca 902743
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI529900WSPRKOOD9HNF272
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressc/o THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, 19801 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 39339252
See how the biggest companies compare on our leaderboards
Natural Health Trends Corp. is an international direct-selling and e-commerce company. Through our subsidiaries, we sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. Our wholly-owned subsidiaries have an active physical presence in the following markets: the Americas, which consists of the United States, Canada, Cayman Islands, Mexico, Peru and Colombia; Greater China, which consists of Hong Kong, Taiwan and China; Southeast Asia, which consists of Malaysia and Singapore; South Korea; Japan; India; and Europe. We also operate in Russia and Kazakhstan through our engagement with a local service provider.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Product brought in 97% of the revenue NATURAL HEALTH TRENDS CORP broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Product | $41.7M | $39.0M |
| Administrative Fees, Freight and Other | $1.5M | $1.1M |
Business segments
Primary Reporting brought in 97% of the revenue NATURAL HEALTH TRENDS CORP broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Primary Reporting | $40.9M | $38.4M |
| China | $1.6M | $946.0K |
| Russia and Kazakhstan | $490.0K | $444.0K |
Regions
Hong Kong brought in 82% of the revenue NATURAL HEALTH TRENDS CORP broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| Hong Kong | $35.1M | $32.7M |
| Taiwan | $1.6M | $1.5M |
| Peru and Colombia | $1.1M | $1.2M |
| United States | $1.0M | $1.2M |
| China | $1.6M | $946.0K |
| Europe | $635.0K | $530.0K |
| Other Foreign Countries | $589.0K | $477.0K |
| Canada | $535.0K | $475.0K |
| Russia and Kazakhstan | $490.0K | $444.0K |
| Japan | $292.0K | $333.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue26¢$10.5M
- Selling, general and admin37¢$14.8M
- Other costs36¢$14.2M
- Income tax1¢$315.0K
Out of $39.8M in revenue.6 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net sales | $39.8M | $43.0M |
| Cost of sales | $10.5M | $11.2M |
| Gross profit | $29.3M | $31.8M |
| Commissions expense | $16.3M | $17.6M |
| Selling, general and administrative expenses | $14.8M | $15.5M |
| Total operating expenses | $31.1M | $33.1M |
| Loss from operations | -$1.8M | -$1.3M |
| Other income, net | $1.2M | $1.9M |
| Income (loss) before income taxes | -$567.0K | $620.0K |
| Income tax provision | $315.0K | $48.0K |
| Net income (loss) | -$882.0K | $572.0K |
| Basic (in dollars per share) | -$0.08 | $0.05 |
| Diluted (in dollars per share) | -$0.08 | $0.05 |
| Basic (in shares) | 11.5M shares | 11.5M shares |
| Diluted (in shares) | 11.5M shares | 11.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $6.8M | $13.5M | |
| Marketable securities | $22.1M | $30.4M | |
| Inventories, net | $2.0M | $3.3M | |
| Other current assets | $3.3M | $3.8M | |
| Total current assets | $34.2M | $51.0M | |
| Property and equipment, net | $153.0K | $190.0K | |
| Operating lease right-of-use assets | $1.9M | $2.5M | |
| Restricted cash | $7.0K | $34.0K | |
| Deferred tax asset | $289.0K | $382.0K | |
| Other assets | $1.9M | $1.3M | |
| Total assets | $38.4M | $55.4M | |
| Accounts payable | $555.0K | $895.0K | |
| Income taxes payable | $5.0K | $4.9M | |
| Accrued commissions | $2.0M | $2.0M | |
| Other accrued expenses | $1.4M | $1.4M | |
| Deferred revenue | $5.6M | $6.4M | |
| Amounts held in eWallets | $2.8M | $3.3M | |
| Operating lease liabilities | $869.0K | $1.1M | |
| Other current liabilities | $451.0K | $709.0K | |
| Total current liabilities | $13.7M | $20.8M | |
| Deferred tax liability | $180.0K | $174.0K | |
| Operating lease liabilities | $1.1M | $1.5M | |
| Total liabilities | $15.0M | $22.5M | |
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding | $0 | $0 | |
| Common stock, $0.001 par value; 50,000,000 shares authorized; 12,979,414 shares issued at December 31, 2025 and 2024 | $13.0K | $13.0K | |
| Additional paid-in capital | $85.0M | $84.9M | |
| Accumulated deficit | -$36.4M | -$26.3M | |
| Accumulated other comprehensive loss | -$784.0K | -$1.3M | |
| Treasury stock, at cost; 1,466,339 shares at December 31, 2025 and 2024 | -$24.4M | -$24.4M | |
| Total stockholders equity | $23.4M | $32.9M | $41.6M |
| Total liabilities and stockholders equity | $38.4M | $55.4M | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, authorized (in shares) | 50.0M shares | 50.0M shares | |
| Common stock, issued (in shares) | 13.0M shares | 13.0M shares | |
| Treasury stock, shares (in shares) | 1.5B shares | 1.5B shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $6.8M | $13.5M | |
| Marketable securities | $22.1M | $30.4M | |
| Inventories, net | $2.0M | $3.3M | |
| Other current assets | $3.3M | $3.8M | |
| Total current assets | $34.2M | $51.0M | |
| Property and equipment, net | $153.0K | $190.0K | |
| Operating lease right-of-use assets | $1.9M | $2.5M | |
| Restricted cash | $7.0K | $34.0K | |
| Deferred tax asset | $289.0K | $382.0K | |
| Other assets | $1.9M | $1.3M | |
| Total assets | $38.4M | $55.4M | |
| Accounts payable | $555.0K | $895.0K | |
| Income taxes payable | $5.0K | $4.9M | |
| Accrued commissions | $2.0M | $2.0M | |
| Other accrued expenses | $1.4M | $1.4M | |
| Deferred revenue | $5.6M | $6.4M | |
| Amounts held in eWallets | $2.8M | $3.3M | |
| Operating lease liabilities | $869.0K | $1.1M | |
| Other current liabilities | $451.0K | $709.0K | |
| Total current liabilities | $13.7M | $20.8M | |
| Deferred tax liability | $180.0K | $174.0K | |
| Operating lease liabilities | $1.1M | $1.5M | |
| Total liabilities | $15.0M | $22.5M | |
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding | $0 | $0 | |
| Common stock, $0.001 par value; 50,000,000 shares authorized; 12,979,414 shares issued at December 31, 2025 and 2024 | $13.0K | $13.0K | |
| Additional paid-in capital | $85.0M | $84.9M | |
| Accumulated deficit | -$36.4M | -$26.3M | |
| Accumulated other comprehensive loss | -$784.0K | -$1.3M | |
| Treasury stock, at cost; 1,466,339 shares at December 31, 2025 and 2024 | -$24.4M | -$24.4M | |
| Total stockholders equity | $23.4M | $32.9M | $41.6M |
| Total liabilities and stockholders equity | $38.4M | $55.4M | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, authorized (in shares) | 50.0M shares | 50.0M shares | |
| Common stock, issued (in shares) | 13.0M shares | 13.0M shares | |
| Treasury stock, shares (in shares) | 1.5B shares | 1.5B shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | -$882.0K | $572.0K |
| Depreciation and amortization | $109.0K | $131.0K |
| Net accretion of marketable securities | -$375.0K | -$441.0K |
| Share-based compensation | $132.0K | $145.0K |
| Noncash lease expense | $1.1M | $1.1M |
| Deferred income taxes | $102.0K | $17.0K |
| Inventories | $1.3M | $1.0M |
| Other current assets | $1.2M | -$113.0K |
| Other assets | -$640.0K | -$421.0K |
| Accounts payable | -$341.0K | -$94.0K |
| Income taxes payable | -$4.9M | -$3.9M |
| Accrued commissions | -$111.0K | -$19.0K |
| Other accrued expenses | -$7.0K | $271.0K |
| Deferred revenue | -$854.0K | $245.0K |
| Amounts held in eWallets | -$445.0K | -$672.0K |
| Operating lease liabilities | -$1.1M | -$1.2M |
| Other current liabilities | -$279.0K | -$62.0K |
| Net cash used in operating activities | -$6.0M | -$3.4M |
| Purchases of property and equipment | -$68.0K | -$57.0K |
| Purchases of marketable securities | -$50.7M | -$70.4M |
| Proceeds from maturities of marketable securities | $59.0M | $40.4M |
| Net cash provided by (used in) investing activities | $8.1M | -$30.1M |
| Dividends paid | -$9.2M | -$9.2M |
| Net cash used in financing activities | -$9.2M | -$9.2M |
| Net decrease in cash, cash equivalents and restricted cash | -$6.7M | -$42.6M |
| Effect of exchange rates on cash, cash equivalents and restricted cash | $312.0K | $5.0K |
| Right-of-use assets obtained in exchange for operating lease liabilities | $487.0K | $124.0K |
No quarter-by-quarter statement was filed.
Corporate structure
NATURAL HEALTH TRENDS CORP sits at the top of its group. 17 entities, 13 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of NATURAL HEALTH TRENDS CORP
- Chris Tahjiun Sharng Filed SCHEDULE 13D on NATURAL HEALTH TRENDS CORP, latest Feb 18, 2026 (2 filings since Apr 16, 2024)
- RENAISSANCE TECHNOLOGIES LLC Filed SC 13G/A on NATURAL HEALTH TRENDS CORP, latest Feb 13, 2024 (3 filings since Feb 11, 2022)
- NATURAL HEALTH TRENDS CORP Rolling Hills Estates, California, United States
- Natural Health Trends Japan, Inc. Subsidiary · Japan
- NHT Global (Canada) Company Subsidiary · Canada
- NHT Global (China) Commodities Co., Ltd. Subsidiary · China
- NHT Global (Zhongshan) Cosmetics Co., Ltd. Subsidiary · China
- NHT Global CIS Company Subsidiary · Cayman Islands
- NHT Global Colombia S.A.S. Subsidiary · Colombia
- NHT Global Europe S.R.L. Subsidiary · Italy
- NHT Global Hong Kong Limited Subsidiary · Hong Kong
- NHT Global Peru S.A.C. Subsidiary · Peru
- NHT Global Taiwan Company Subsidiary · Cayman Islands
- NHTC (India) Private Limited Subsidiary · India
- NHTC Global Singapore Pte. Ltd. Subsidiary · Singapore
- NHTC Holding Company Subsidiary · Cayman Islands
- NHTC Trading Company Subsidiary · Cayman Islands
- NHTC Wellness Products Malaysia Sdn. Bhd. Subsidiary · Malaysia
- NHTK Ltd. Subsidiary · South Korea
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What NATURAL HEALTH TRENDS CORP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Furniture and fixtures | $171.0K6 Dec 31, 2025 | $241.0K6 Dec 31, 2024 | −29.0% |
| Computer equipment and software | $1.1M6 Dec 31, 2025 | $1.0M6 Dec 31, 2024 | +4.8% |
| Leasehold improvements | $554.0K6 Dec 31, 2025 | $753.0K6 Dec 31, 2024 | −26.4% |
| Construction in progress | $011 Dec 31, 2024 | $40.0K11 Dec 31, 2023 | −100.0% |
| Property and equipment, before depreciation | $2.3M6 Dec 31, 2025 | $2.5M6 Dec 31, 2024 | −8.1% |
| Accumulated depreciation | $2.1M6 Dec 31, 2025 | $2.3M6 Dec 31, 2024 | −7.1% |
| Property and equipment, net | $153.0K6 Dec 31, 2025 | $190.0K6 Dec 31, 2024 | −19.5% |
| Operating-lease assets (leased space) | $1.9M6 Dec 31, 2025 | $2.5M6 Dec 31, 2024 | −25.2% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $6.8M6 Dec 31, 2025 | $13.5M6 Dec 31, 2024 | −49.7% |
| Marketable securities, current | $22.1M6 Dec 31, 2025 | $30.4M6 Dec 31, 2024 | −27.5% |
| Debt securities available for sale | $23.0M6 Dec 31, 2025 | $36.0M6 Dec 31, 2024 | −36.2% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $2.0M6 Dec 31, 2025 | $3.3M6 Dec 31, 2024 | −37.4% |
| Finished goods | $1.8M6 Dec 31, 2025 | $2.8M6 Dec 31, 2024 | −34.7% |
Properties, in its own words
Our corporate headquarters is located in Rolling Hills Estates, California where we lease 4,900 square feet of office space with a term expiring in September 2030. In January 2026, the Company executed an agreement to sublease a portion of this space for the duration of the lease term, effective February 1, 2026. We also lease 7,300 square feet of corporate office space in Hong Kong with a term expiring in June 2026. To help further develop the market for our products in North America, we lease retail space in Richmond, British Columbia and Metuchen, New Jersey. Our office space in Rolling Hills Estates and Hong Kong is used in support of all of our business segments, while the North America retail space is used in support of our Primary Reporting Segment.
We lease seven branch offices throughout China that are used for our China business segment, and additional office space in Peru, Japan, Taiwan, South Korea, Malaysia, India, Colombia and the Cayman Islands (all of which are used for our Primary Reporting Segment). We contract with third parties for fulfillment and distribution operations in all of our international markets. We believe that our existing office space is in good condition, and is suitable and adequate for the conduct of our business.
Item 2 of the 10-K filed Feb 20, 2026.5
Leadership
Who has led NATURAL HEALTH TRENDS CORP, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerRobert H. Hesse Mar 17, 2006 to Mar 17, 200614
- Chief executive officerStephanie S. Hayano Aug 8, 2006 to Aug 8, 200615
- PresidentJohn Francis Cavanaugh Feb 1, 2007 to Sep 18, 200816
- PresidentCurtis E. Broome Mar 1, 2007 to Jan 3, 200817
- PresidentChris Tahjiun Sharng Apr 24, 2007 to now18
- PresidentStephanie S. Hayano Aug 8, 2006 to Aug 8, 200615
- Chief financial officerTimothy Scott Davidson Apr 24, 2007 to now19
- Chief financial officerChris Tahjiun Sharng Aug 25, 2006 to Feb 13, 200720
- Chief operating officerGernot Senke Feb 13, 2007 to Feb 13, 200721
Board members and other officers (17)
- Chief Accounting OfficerTimothy Scott Davidson Feb 13, 2007 to Feb 13, 200722
- Board memberEllen Sun Jun 8, 2026 to now23
- Board memberLucy Njeri Nduati Aug 7, 2024 to now24
- Board memberBrunde E. Broady May 18, 2021 to Dec 16, 202225
- Board memberChing Chung Wong Jun 4, 2020 to now26
- Board memberChris Tahjiun Sharng Jan 22, 2015 to now27
- Board memberKin Yep Chung Feb 17, 2015 to Jun 4, 202028
- Board memberYiu Tung Chan Dec 16, 2015 to now29
- Board memberGeorge K. Broady Oct 27, 2008 to Dec 27, 202130
- Board memberAnthony B. Martino Feb 2, 2007 to Jul 25, 200731
- Board memberTerrence M. Morris Feb 2, 2007 to Feb 13, 200732
- Board memberBrian Wolfson Sir. Feb 13, 2007 to Apr 24, 200733
- Board memberRandall A. Mason Feb 13, 2007 to now34
- Board memberStefan Zuckut Jun 6, 2007 to Jul 2, 200935
- Board memberRobert H. Hesse Mar 17, 2006 to Mar 17, 200614
- Board memberStephanie S. Hayano Aug 8, 2006 to Aug 8, 200615
- Board memberBrien Colin O. Aug 21, 2006 to Nov 27, 200636
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- NHT Global (Canada) Company Canada4
- NHT Global (China) Commodities Co., Ltd. China4
- NHT Global (Zhongshan) Cosmetics Co., Ltd. China4
- NHT Global CIS Company Cayman Islands4
- NHT Global Colombia S.A.S. Colombia4
- NHT Global Europe S.R.L. Italy4
- NHT Global Hong Kong Limited Hong Kong4
- NHT Global Peru S.A.C. Peru4
- NHT Global Taiwan Company Cayman Islands4
- NHTC (India) Private Limited India4
- NHTC Global Singapore Pte. Ltd. Singapore4
- NHTC Holding Company Cayman Islands4
- NHTC Trading Company Cayman Islands4
- NHTC Wellness Products Malaysia Sdn. Bhd. Malaysia4
- NHTK Ltd. South Korea4
- Natural Health Trends Japan, Inc. Japan4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Jul 29, 20268-K Results of operations37
- May 7, 20268-K Executive or director change; Shareholder vote38
- Apr 29, 20268-K Results of operations39
- Feb 17, 20268-K Entered a material agreement; Other events40
- Feb 4, 20268-K Results of operations41
- Nov 5, 20258-K Results of operations42
- Jul 30, 20258-K Results of operations43
- May 6, 20258-K Shareholder vote44
- Apr 30, 20258-K Results of operations45
- Apr 2, 20258-K Executive or director change46
- Mar 13, 20258-K Change of auditor47
- Feb 5, 20258-K Results of operations48
- Aug 8, 2006New chief executive Stephanie S. Hayano becomes CEO15
- Mar 17, 2006New chief executive Robert H. Hesse becomes CEO14
Calendar
Coming up
- Nov 4, 2026Reports results for the quarter ending Sep/202649
When it reported results
- Jul 29, 2026Reported quarterly or annual results37
- Apr 29, 2026Reported quarterly or annual results39
- Feb 4, 2026Reported quarterly or annual results41
- Nov 5, 2025Reported quarterly or annual results42
- Jul 30, 2025Reported quarterly or annual results43
- Apr 30, 2025Reported quarterly or annual results45
- Feb 5, 2025Reported quarterly or annual results48
- Oct 30, 2024Reported quarterly or annual results50
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
143 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 34 major events, 70 insider forms, 5 large holders, 1 private raises, 13 other. The latest 20:
- Jul 29, 202610-Q EDGAR
- Jul 29, 20268-K EDGAR
- Jun 8, 20263 EDGAR
- May 7, 20268-K EDGAR
- Apr 29, 202610-Q EDGAR
- Apr 29, 20268-K EDGAR
- Mar 30, 2026ARS EDGAR
- Mar 24, 2026DEFA14A EDGAR
- Mar 24, 2026DEF 14A EDGAR
- Mar 24, 2026DEF 14A EDGAR
- Feb 20, 202610-K EDGAR
- Feb 18, 2026SCHEDULE 13D EDGAR
- Feb 17, 20268-K EDGAR
- Feb 4, 20268-K EDGAR
- Nov 5, 202510-Q EDGAR
- Nov 5, 20258-K EDGAR
- Jul 30, 202510-Q EDGAR
- Jul 30, 20258-K EDGAR
- May 6, 20258-K EDGAR
- Apr 30, 202510-Q EDGAR
The 143 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Chris Tahjiun SharngSCHEDULE 13D, 2 filings Apr 16, 2024 to Feb 18, 202651
- RENAISSANCE TECHNOLOGIES LLCSC 13G/A, 3 filings Feb 11, 2022 to Feb 13, 202452
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Chris T. SharngPresident | 62 | $1.0M | $1.2M53 |
| 2025 | Timothy S. DavidsonChief Financial Officer, Senior Vice President and Corporate Secretary | 55 | $400.0K | $480.5K53 |
| 2024 | Chris T. SharngPresident | 62 | $1.0M | $1.3M53 |
| 2024 | Timothy S. DavidsonChief Financial Officer, Senior Vice President and Corporate Secretary | 55 | $400.0K | $519.8K53 |
Money raised
Private offerings the company reported to the SEC on Form D.
- Feb 6, 2023Raised $42,592 in a private offering of equity Form D: 4 investors so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How NATURAL HEALTH TRENDS CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARNATURAL HEALTH TRENDS CORP1
- CIK0000912061
- Employer ID (EIN)59-27053365
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inDelaware5
- Fiscal year endsDecember 311
- Industry code (SIC)5190 Wholesale-Miscellaneous Nondurable Goods1
- SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
- Business address609 Deep Valley Drive, Suite 395, Rolling Hills Estates, CA 902741
- Phone310-541-08881
- Shares outstanding8,577,848 as of Apr 24, 202613
- Public float$32.4M as of Jun 30, 20255
- AuditorCBIZ CPAs P.C., Los Angeles, CA PCAOB ID 199; no auditor attestation of internal control over financial reporting5
- On EDGAR sinceMay 15, 19961
- Filings946 in all: 4 (261), 8-K (224), 10-Q (64), 3 (26), 10QSB (25), DEF 14A (25), SC 13G/A (24), 10-K (21)1
All 48 form types
144 (21), NT 10-Q (21), SC 13G (20), 4/A (18), 10QSB/A (15), DEFA14A (14), EFFECT (12), SC 13D/A (12), POS AM (11), UPLOAD (11), NT 10-K (10), 10KSB (8), 5 (8), 8-K/A (8), PRE 14A (8), S-3/A (8), CORRESP (7), SC 13D (7), 424B3 (5), ARS (5), 10-K/A (4), 10KSB/A (4), S-1 (4), S-1/A (4), S-3 (4), S-8 (4), S-8 POS (4), PRER14A (3), REGDEX (3), 3/A (2), D (2), 10-Q/A (1), 25-NSE (1), 424B1 (1), 8-A12B (1), CERTNAS (1), PRES14A (1), SC TO-I (1), SC TO-I/A (1), SCHEDULE 13D (1)
- Latest filingsAnnual report (10-K) Feb 20, 2026
Quarterly report (10-Q) Jul 29, 2026
Proxy statement (DEF 14A) Mar 24, 2026
Latest 8-K (8-K) Jul 29, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.001 per share | NHTC | NASDAQ |
From the cover page of the 10-K filed Feb 20, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks NATURAL HEALTH TRENDS CORP names in Item 1A of its 10-K filed Feb 20, 2026: 38 risks under these headings, as written.5
- Business, Product and Market Risks
- Because our Hong Kong operations account for a substantial portion of our overall business, and substantially all of our Hong Kong business is derived from the sale of products to members in China, any material adverse change in our business relating to either Hong Kong or China would likely have a material adverse impact on our overall business.
- Hong Kong's political and economic landscape has in recent years undergone significant change, and this upheaval or related consequences could negatively impact our business and financial performance.
- We experienced negative operating cash flows during each of the four years ended December 31, 2022 through 2025, and only modest positive operating cash flows during the years ended December 31, 2021 and 2020. Unless our operating cash flows improve, this negative financial performance could have a material adverse effect on our business and our stock price.
- Adverse publicity associated with our products, ingredients or network marketing program, or those of similar companies, could harm our financial condition and operating results.
- Our business and financial performance may be adversely affected by unfavorable economic and market conditions and the uncertain geopolitical environment.
- Changes in government trade and economic policies, including the imposition of tariffs and other restrictive trade policies, and ongoing political and economic disputes between the United States and other jurisdictions, particularly China, may have a negative effect on global economic conditions and our business, financial results and financial condition.
- We are subject to risks relating to product concentration and lack of revenue diversification.
- Epidemics, natural disasters, terrorist attacks or acts of war or hostility may seriously harm our business.
- The high level of competition in our industry could adversely affect our business.
- Failure of new products to gain member and market acceptance could harm our business.
- We rely on a limited number of independent third parties to manufacture and supply our products on a timely basis.
The other 27 risks
- Growth may be impeded by the political and economic risks of entering and operating in foreign markets.
- Failure to maintain effective internal controls in accordance with the Sarbanes-Oxley Act of 2002 could negatively impact our business and the market price of our common stock.
- Management and Member Network Risks
- We could be adversely affected by management changes or an inability to attract and retain key management, directors and consultants.
- Our continuing loss of a significant number of members is adversely affecting our business, and if we cannot stabilize or increase the number of members our business could be further negatively impacted.
- Although virtually all of our members are independent contractors, improper member actions that violate laws or regulations could harm our business.
- An increase in the amount of compensation paid to members would reduce profitability.
- We may be held responsible for certain taxes or assessments relating to the activities of our members and service providers, which could harm our financial condition and operating results.
- Legal, Regulatory, Tax and Currency Risks
- Our business in China is subject to compliance with a myriad of applicable laws and regulations, and any actual or alleged violations of those laws or government actions otherwise directed at us could have a material adverse impact on our business and the value of our company.
- Direct-selling laws and regulations may prohibit or severely restrict our direct sales efforts and cause our revenue and profitability to decline, and regulators could adopt new regulations that harm our business.
- Challenges by third parties to the legality of our business operations could harm our business.
- We have in the past been involved in, and may in the future face, lawsuits, claims, and governmental proceedings and inquiries that could harm our business.
- Currency exchange rate fluctuations could lower our revenue and profitability.
- Changes in tax or duty laws, and unanticipated tax or duty liabilities, could adversely affect our net income.
- Transfer pricing regulations affect our business and results of operations.
- Our products and related activities are subject to extensive government regulation, which could delay, limit or prevent the sale of some of our products in some markets.
- New regulations governing the marketing and sale of nutritional supplements could harm our business.
- Regulations governing the production and marketing of our personal care products could harm our business.
- If we are found not to be in compliance with good manufacturing practices our operations could be harmed.
- Failure to comply with domestic and foreign laws and regulations governing product claims and advertising could harm our business.
- We are subject to anti-bribery laws, including the U.S. Foreign Corrupt Practices Act.
- We do not have a comprehensive product liability insurance program and product liability claims could hurt our business.
- Intellectual Property, Information Technology and Cybersecurity Risks
- We may be unable to protect or use our intellectual property rights.
- We rely on and are subject to risks associated with our reliance upon information technology systems.
- System disruptions or failures, cybersecurity risks, and compromises of data, or the failure to comply with related laws and regulations, could harm our business.
- Our systems, software and data reside on third-party servers, exposing us to risks that disruption or intrusion of those servers could temporarily or permanently interrupt our access and damage our business.
- Common Stock Risks
- Our common stock is particularly subject to volatility because of the industry and markets in which we operate.
- Our common stock continues to experience wide fluctuations in trading volumes and prices. This may make it more difficult for holders of our common stock to sell shares when they want and at prices they find attractive.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARJohn Francis Cavanaugh, President
- 17SEC EDGARCurtis E. Broome, President
- 18SEC EDGARChris Tahjiun Sharng, President
- 19
- 20
- 21
- 22
- 23SEC EDGAREllen Sun, Board member
- 24SEC EDGARLucy Njeri Nduati, Board member
- 25SEC EDGARBrunde E. Broady, Board member
- 26SEC EDGARChing Chung Wong, Board member
- 27SEC EDGARChris Tahjiun Sharng, Board member
- 28SEC EDGARKin Yep Chung, Board member
- 29SEC EDGARYiu Tung Chan, Board member
- 30SEC EDGARGeorge K. Broady, Board member
- 31SEC EDGARAnthony B. Martino, Board member
- 32SEC EDGARTerrence M. Morris, Board member
- 33SEC EDGARBrian Wolfson Sir., Board member
- 34SEC EDGARRandall A. Mason, Board member
- 35SEC EDGARStefan Zuckut, Board member
- 36SEC EDGARBrien Colin O., Board member
- 37SEC EDGARResults of operations
- 38
- 39SEC EDGARResults of operations
- 40
- 41SEC EDGARResults of operations
- 42SEC EDGARResults of operations
- 43SEC EDGARResults of operations
- 44SEC EDGARShareholder vote
- 45SEC EDGARResults of operations
- 46SEC EDGARExecutive or director change
- 47SEC EDGARChange of auditor
- 48SEC EDGARResults of operations
- 49NasdaqNasdaq calendar
- 50
- 51
- 52
- 53